These analyses also indicated that ERO1α is expressed at elevated levels in pancreatic cancers relative to adjacent healthy tissues from the same patient, and that high tumor expression of this enzyme is significantly correlated with short survival duration. The gene discussed is ERO1A; the disease is familial pancreatic carcinoma.